The TCGA cohort of patients with ccRCC exhibited a higher percentage of CD4+ T cells compared to those with pRCC, with respective percentages of 17.60% and 15.70% (p<0.01). The gene discussed is CD4; the disease is nonpapillary renal cell carcinoma.